ÂÜÀòÂÒÂ×

Edward Gleeson, QA, MBA, has extensive experience in quality assurance within the pharmaceutical industry. Currently serving as Senior Manager of GMP Quality Assurance at Mirum Pharmaceuticals, Inc., since May 2022, Gleeson oversees the QA final disposition of Volixibat Finished Goods and is involved in the review and approval of label texts. Prior experience includes leading QA operations for Novavax Inc. during the COVID vaccine launch, managing CMC Quality Assurance at Omeros Corporation, and overseeing quality operations for combination products at Antares Pharma Inc. Gleeson's early career included roles at Laureate, Dendreon, and ImClone Systems, demonstrating a solid foundation in quality assurance practices and leadership. Edward Gleeson holds an MBA from the New Jersey Institute of Technology and a BASc in Biological Sciences from Rutgers University–New Brunswick.